Literature DB >> 7213726

Enhanced concanavalin A agglutination of trypsinised erythrocytes is due to a specific class of aggregation.

R G Greig, D E Brooks.   

Abstract

Using the output of a rotational viscometer as a continuous index of aggregation, we have shown previously that the concanavalin A agglutination of native human erythrocytes can be resolved into three distinct classes of aggregation, static, type I and type II. Static aggregation occurs in the absence of shear forces while both type I and II aggregations are shear-induced. We now report that the increased concanavalin A agglutination of trypsinised erythrocytes is attributable to a specific enhancement in the development of type II aggregation. While type II formation in native cell suspensions requires high concanavalin A concentrations and continual shearing, an indistinguishable type of aggregation develops in suspensions of trypsinised red cells at considerably lower lectin concentrations and in the absence of applied shear forces.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213726     DOI: 10.1016/0005-2736(81)90497-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Contact patterns in concanavalin A agglutinated erythrocytes.

Authors:  H Darmani; W T Coakley
Journal:  Cell Biophys       Date:  1991-02

2.  Involvement of the MN blood group antigen in shear-enhanced hemagglutination induced by the Escherichia coli F41 adhesin.

Authors:  D E Brooks; J Cavanagh; D Jayroe; J Janzen; R Snoek; T J Trust
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

3.  Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.

Authors:  Vicente P Martins; Suellen B Morais; Carina S Pinheiro; Natan R G Assis; Barbara C P Figueiredo; Natasha D Ricci; Juliana Alves-Silva; Marcelo V Caliari; Sergio C Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2014-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.